797 filings
4
Altman Peter
19 Apr 24
BioCardia / Peter Altman ownership change
5:38pm
DEF 14A
BCDA
BioCardia Inc.
Definitive proxy
15 Apr 24
5:16pm
SC 13D/A
Frost Gamma Investments Trust
5 Apr 24
BioCardia / Frost Gamma Investments Trust ownership change
4:13pm
PRE 14A
BCDA
BioCardia Inc.
Preliminary proxy
4 Apr 24
5:02pm
EFFECT
BCDA
BioCardia Inc.
2 Apr 24
Notice of effectiveness
12:15am
4
Altman Peter
28 Mar 24
BioCardia / Peter Altman ownership change
7:33pm
S-8
BCDA
BioCardia Inc.
27 Mar 24
Registration of securities for employees
4:09pm
8-K
BCDA
BioCardia Inc.
27 Mar 24
BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
4:07pm
10-K
2023 FY
BCDA
BioCardia Inc.
Annual report
27 Mar 24
4:05pm
8-K
BCDA
BioCardia Inc.
13 Mar 24
BioCardia and StemCardia Announce Biotherapeutic Delivery Partnership
7:00am
8-K
BCDA
BioCardia Inc.
12 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:33pm
8-K
BCDA
BioCardia Inc.
12 Mar 24
BioCardia Announces CMS Approval of Coverage for CardiAMP Cell Therapy Confirmatory Phase III Heart Failure Study
7:00am
8-K
BCDA
BioCardia Inc.
4 Mar 24
Regulation FD Disclosure
8:00am
SC 13D/A
BCDA
BioCardia Inc.
27 Feb 24
BioCardia / Frost Gamma Investments Trust ownership change
4:53pm
4
Altman Peter
15 Feb 24
BioCardia / Peter Altman ownership change
7:00am
SC 13G/A
Satterfield Thomas A JR
14 Feb 24
BioCardia / SATTERFIELD THOMAS A JR ownership change
5:06pm
S-3
BCDA
BioCardia Inc.
Shelf registration
14 Feb 24
4:17pm
8-K
BCDA
BioCardia Inc.
9 Feb 24
Unregistered Sales of Equity Securities
9:58am
8-K
BCDA
BioCardia Inc.
8 Feb 24
BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA
7:03am
SC 13D/A
BCDA
BioCardia Inc.
6 Feb 24
BioCardia / Frost Gamma Investments Trust ownership change
4:28pm